Device / Technology News

RSS

BioStreamline project outcomes

CPI have reported successful outcomes the £11.

From Fluidic Sciences and Sphere Bio 16 Oct 2019

Sphere Fluidics introduces Cyto-Cellect Human IgGK Detection Kit

Sphere Fluidics, introduced the Cyto-Cellect Human IgGK Detection Kit, to be used in conjunction with the Cyto-Mine® Single Cell Analysis System.

From Fluidic Sciences and Sphere Bio 16 Oct 2019

Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK

Sphere Fluidics, announce it has opened a new office space at Granta Park. New facilities support the Company’s accelerated expansion.

From Fluidic Sciences and Sphere Bio 16 Oct 2019

We are excited to release our latest software update with new Cyto-Mine functionalities!

The Cyto-Mine Studio Suite contains a collection of software to allow Cyto-Mine operation and data acquisition.

From Fluidic Sciences and Sphere Bio 16 Oct 2019

Sphere Fluidics closes a $4.8 million USD (£3.7 million) funding round

Sphere Fluidics, announced that it has closed an additional tranche of investment of $2.9 million, securing a total of $4.8 million in investment.

From Fluidic Sciences and Sphere Bio 16 Oct 2019

BioStreamline: Streamlining the development of next generation biotherapeutics

A collaboration to streamline the development of cost-effective next generation biotherapeutics will host a dissemination event at CPI.

From Fluidic Sciences and Sphere Bio 16 Oct 2019

Sphere Fluidics hires 10 new UK and US staff in its plan to scale internationally

Sphere Fluidics, announced today that it has appointed six new employees and plans to hire four more staff in its UK and US sites.

From Fluidic Sciences and Sphere Bio 16 Oct 2019

Sphere Fluidics closes $2 million USD (c. £1.5 million GBP) investment round

Sphere Fluidics, announced that is has closed a $2 million (circa £1.5 million) investment round.

From Fluidic Sciences and Sphere Bio 16 Oct 2019

Sphere Fluidics is a finalist in the Medicine Maker Innovation Awards and now needs a public vote

We have been voted as one of the most groundbreaking technologies of 2018 in the Medicine Maker Innovation Awards!

From Fluidic Sciences and Sphere Bio 16 Oct 2019

Telescope technology used to take first undistorted images of eye area involved in glaucoma

Using methods originally developed by astronomers to view stars more clearly through Earth's atmosphere, optometry researchers at Indiana University have taken the first undistorted microscopic images of a part of the eye involved in glaucoma.

16 Oct 2019

Insilico Medicine presents experimentally validated model for drug discovery at NeurIPS 2019

Insilico Medicine, a biotechnology company developing an end-to-end drug discovery pipeline utilizing next-generation artificial intelligence, is proud to present its paper "A Prior of a Googol Gaussians: a Tensor Ring Induced Prior for Generative Models" at the 33rd Conference on Neural Information Processing Systems (NeurIPS).

16 Oct 2019

New initiative aims to use artificial intelligence to identify early drug candidates

Insilico Medicine, in collaboration with ChemDiv, Inc., launched a drug discovery initiative that aims to use the power of artificial intelligence for screening chemistry space with newly designed compounds.

16 Oct 2019

White noise listening device for monitoring infant breathing

Researchers at the University of Washington have come up with a device which acts as a monitor for infant breathing patterns while playing white noise to soothe them to sleep. The results of their study with the new device would be presented in an article titled, “Contactless Infant Monitoring using White Noise,” at the MobiCom 2019 conference in Los Cabos, Mexico on the 22nd of this month.

15 Oct 2019

Machine learning system may offer warnings about negative side effects of drug-drug interactions

The more medications a patient takes, the greater the likelihood that interactions between those drugs could trigger negative side effects, including long-term organ damage and even death.

15 Oct 2019

AI detects over 95 percent of diabetic retinopathy cases

A new study presented at the Annual Meeting of the American Academy of Ophthalmologists (AAO) on October 14, 2019 reports an astonishing 95.% yield when artificial intelligence (AI) is used to screen a real life population for diabetic retinopathy.

15 Oct 2019

Scientists develop more accurate method to find good targets for cancer immunotherapy

Ludwig Cancer Research scientists have developed a new and more accurate method to identify the molecular signs of cancer likely to be presented to helper T cells, which stimulate and orchestrate the immune response to tumors and infectious agents.

15 Oct 2019

PAP therapy associated with reduced acute care visits for patients with obstructive sleep apnea

Treating patients with moderate or severe obstructive sleep apnea with positive airway pressure (PAP) therapy is associated with reduced acute care visits and health care expenditures, according to a recent study.

15 Oct 2019

FFEI wins IOP Business Innovation Award 2019

FFEI Ltd, the global developer of award-winning digital imaging solutions, today announced that the Institute of Physics has recognized FFEI for the development of advanced whole slide imaging technology in the field of digital pathology, by awarding the IOP Business Innovation Award 2019.

15 Oct 2019

Electrical brain implants enable patient to have 'mind control' of motorized prosthetic arms

In a set of proof-of-concept experiments, Johns Hopkins researchers have implanted electrodes in both sides of the brain of a person who is mostly paralyzed — with minimal sensation in his hands — to enable him to have some “mind control” of motorized prosthetic arms.

From Johns Hopkins Medicine 15 Oct 2019

CANDO drug discovery platform focuses on finding new medications for mental illnesses

An estimated 46.6 million U.S. adults struggle with mental illnesses, such as anxiety disorder, according to the National Institute of Mental Health. About half of millennials and 75% of Gen-Zers report having quit jobs for mental health reasons.

15 Oct 2019

Device / Technology News

BioStreamline project outcomes

Sphere Fluidics introduces Cyto-Cellect Human IgGK Detection Kit

Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK

We are excited to release our latest software update with new Cyto-Mine functionalities!

Sphere Fluidics closes a $4.8 million USD (£3.7 million) funding round

BioStreamline: Streamlining the development of next generation biotherapeutics

Sphere Fluidics hires 10 new UK and US staff in its plan to scale internationally

Sphere Fluidics closes $2 million USD (c. £1.5 million GBP) investment round

Sphere Fluidics is a finalist in the Medicine Maker Innovation Awards and now needs a public vote

Telescope technology used to take first undistorted images of eye area involved in glaucoma

Insilico Medicine presents experimentally validated model for drug discovery at NeurIPS 2019

New initiative aims to use artificial intelligence to identify early drug candidates

White noise listening device for monitoring infant breathing

Machine learning system may offer warnings about negative side effects of drug-drug interactions

AI detects over 95 percent of diabetic retinopathy cases

Scientists develop more accurate method to find good targets for cancer immunotherapy

PAP therapy associated with reduced acute care visits for patients with obstructive sleep apnea

FFEI wins IOP Business Innovation Award 2019

Electrical brain implants enable patient to have 'mind control' of motorized prosthetic arms

CANDO drug discovery platform focuses on finding new medications for mental illnesses

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News